专题:Melanoma and MAPK Pathways

This cluster of papers focuses on the mammalian MAP kinase signaling pathways, particularly their role in cancer, with a specific emphasis on melanoma. It covers the genetic mutations, targeted therapies, resistance mechanisms, and the impact of MAP kinase pathways on cell proliferation and immune response.
最新文献
Molecular glue degraders of HuR suppress BRAF-mutant colorectal cancer

article Full Text OpenAlex

Disrupted molecular glue complex drives RAS inhibitor resistance

article Full Text OpenAlex

Assessment of survival benefit from sentinel node biopsy for melanoma: a systematic review and meta-analysis

review Full Text OpenAlex

Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology

review Full Text OpenAlex

Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB–IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 study

article Full Text OpenAlex

Emerging landscape of KRAS inhibitors in cancer treatment

review Full Text OpenAlex

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial

article Full Text OpenAlex

Drug Therapy for Melanoma: Current Updates and Future Prospects

review Full Text OpenAlex

Properties of FDA-approved small molecule protein kinase inhibitors: A 2026 update

review Full Text OpenAlex

GCN5–ERK lactylation–phosphorylation loop amplifies lactate-driven cancer progression

article Full Text OpenAlex

近5年高被引文献